SCHEMBL31040355

SCHEMBL31040355

CC(C)(C)OC(=O)N1CCC(C2CCCCN2C(=O)OCc2ccccc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
HTT P42858 1/20 0.50
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
STS P08842 1/20 0.49
CYP2C19 P33261 1/20 0.49
TMEM97 Q5BJF2 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
FKBP1A P62942 1/20 0.48
KDM4E B2RXH2 1/20 0.47
PKM P14618 1/20 0.47
CCR5 P51681 1/20 0.46
PREP P48147 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20320016 0.93 SMN1; SMN2 (0.55) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL31726707 0.93 SMN1; SMN2 (0.55) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL31727301 0.89 SMN1; SMN2 (0.56) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL31727280 0.89 SMN1; SMN2 (0.56) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL18428244 0.88 JAK2 (0.52) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL18477527 0.87 FKBP1A (0.52) TMEM97SIGMAR1FKBP1APREP
SCHEMBL13954406 0.86 GPR119 (0.67) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL2960273 0.84 PREP (0.57) FKBP1APREP
SCHEMBL1586077 0.84 JAK2 (0.55) GPR119SMN1; SMN2NPC1RAB9AHTT
SCHEMBL8569488 0.84 CCR5 (0.53) GPR119SMN1; SMN2NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4714446-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2026-03-25 EP disclosed
EP-4413985-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2024-08-14 EP disclosed